Kenichi Ogawa Selected Research

Kenichi Ogawa Research Topics

4	Polyneuropathies (Polyneuropathy) 03/2021 - 07/2006
3	Myocardial Infarction 01/2005 - 05/2003
2	Genetic Predisposition to Disease (Genetic Predisposition) 11/2011 - 04/2006
2	Diabetic Neuropathies (Diabetic Neuropathy) 01/2010 - 04/2006
1	Cancer Pain 06/2023
1	Diarrhea 12/2022
1	Hypotension (Low Blood Pressure) 12/2022
1	Atrophy 03/2021
1	Dementia (Dementias) 03/2019
1	Peripheral Nervous System Diseases (PNS Diseases) 02/2014
1	Hyperalgesia 02/2014
1	Hypersensitivity (Allergy) 02/2014
1	Neuralgia (Stump Neuralgia) 02/2014
1	Muscle Cramp (Cramp) 11/2011
1	Pruritus (Itching) 01/2010
1	Diabetic Foot 07/2006
1	Ulcer 07/2006
1	Neurologic Manifestations (Neurological Manifestations) 04/2006
1	Hypertension (High Blood Pressure) 10/2005
1	Dysuria 10/2005
1	Sleep Initiation and Maintenance Disorders (Insomnia) 10/2005
1	Paresthesia (Dysesthesia) 10/2005
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 10/2005
1	Myocardial Ischemia (Ischemic Heart Diseases) 10/2005
1	Cardiovascular Diseases (Cardiovascular Disease) 10/2005
1	Anorexia 10/2005
1	Embolism (Embolus) 01/2005
1	Atherosclerotic Plaque (Atheroma) 01/2005
1	Thrombosis (Thrombus) 01/2005
1	Keloid 03/2004
1	Ventricular Remodeling 05/2003
1	Myocardial Reperfusion Injury 05/2003
1	Heart Diseases (Heart Disease) 02/2002

2	NAD (NADH)IBA 01/2010 - 07/2006
1	Analgesics (Analgesic Drugs)IBA 06/2023
1	EDBAIBA 03/2021
1	Serum AlbuminIBA 03/2019
1	Adenosine Monophosphate (AMP)IBA 09/2018
1	Nerve Growth Factors (Neurotrophins)IBA 02/2014
1	Nerve Growth Factor (NGF)IBA 02/2014
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 02/2014
1	staurosporine aglycone (K252a)IBA 02/2014
1	Paclitaxel (Taxol)FDA LinkGeneric 02/2014
1	Codon (Codons)IBA 11/2011
1	prolyl-proline (Pro-Pro)IBA 11/2011
1	Glutathione Peroxidase GPX1IBA 11/2011
1	prolylleucineIBA 11/2011
1	Mitochondrial Uncoupling ProteinsIBA 04/2006
1	Insulin (Novolin)FDA Link 10/2005
1	Atrial Natriuretic Factor (ANF)IBA 05/2003
1	Brain Natriuretic Peptide (Natrecor)FDA Link 02/2002

2	Therapeutics 10/2005 - 01/2005
1	Punctures 12/2022
1	Glycemic Control 10/2005
1	Percutaneous Coronary Intervention 01/2005
1	Stents 01/2005
1	Embolic Protection Devices 01/2005
1	Catheters 01/2005
1	Counterpulsation (External Counterpulsation) 11/2004
1	Radiotherapy 03/2004
1	Intravenous Infusions 05/2003